Shenzhen Historical Income Statement
002551 Stock | 3.38 0.08 2.42% |
Historical analysis of Shenzhen Glory income statement accounts such as Selling General Administrative of 103.2 M, Total Revenue of 1.2 B or Cost Of Revenue of 901.2 M can show how well Shenzhen Glory Medical performed in making a profits. Evaluating Shenzhen Glory income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Shenzhen Glory's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Shenzhen Glory Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shenzhen Glory Medical is a good buy for the upcoming year.
Shenzhen |
About Shenzhen Income Statement Analysis
Shenzhen Glory Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shenzhen Glory shareholders. The income statement also shows Shenzhen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Shenzhen Glory Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Shenzhen Glory Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Cost Of Revenue
Cost of Revenue is found on Shenzhen Glory Medical income statement and represents the costs associated with goods and services Shenzhen Glory provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Most accounts from Shenzhen Glory's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Shenzhen Glory Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Glory Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Shenzhen Glory's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 103.2 M, whereas Operating Income is projected to grow to (18.9 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 362.9M | 221.9M | 197.6M | 319.4M | Research Development | 52.4M | 48.2M | 40.1M | 52.2M |
Shenzhen Glory income statement Correlations
Click cells to compare fundamentals
Shenzhen Glory Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Shenzhen Glory income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 12.1M | 17.0M | 7.2M | 4.4M | 2.0M | 3.5M | |
Selling General Administrative | 96.4M | 246.3M | 115.0M | 64.9M | 54.1M | 103.2M | |
Total Revenue | 1.5B | 2.3B | 1.8B | 1.3B | 1.2B | 1.2B | |
Operating Income | 126.6M | 383.2M | 95.0M | (6.5M) | (19.9M) | (18.9M) | |
Cost Of Revenue | 1.2B | 1.6B | 1.4B | 1.1B | 995.3M | 901.2M | |
Income Before Tax | 70.8M | 368.5M | 89.1M | (384.4M) | (127.6M) | (121.3M) | |
Net Income Applicable To Common Shares | 59.8M | 162.1M | 59.3M | (308.1M) | (277.3M) | (263.4M) | |
Net Income | 59.8M | 162.1M | 59.3M | (308.1M) | (148.9M) | (141.4M) | |
Income Tax Expense | (5.6M) | (1.5M) | 1.0M | (56.5M) | (50.8M) | (48.3M) | |
Minority Interest | 479.5M | 664.1M | (28.7M) | 19.8M | 11.9M | 11.3M | |
Research Development | 47.9M | 61.2M | 52.4M | 48.2M | 40.1M | 52.2M | |
Gross Profit | 329.8M | 694.7M | 362.9M | 221.9M | 197.6M | 319.4M | |
Other Operating Expenses | 15.5M | 18.6M | 12.1M | 10.6M | 9.5M | 15.0M | |
Net Income From Continuing Ops | 76.4M | 369.9M | 88.0M | (327.9M) | (160.8M) | (152.8M) | |
Ebit | 49.6M | 400.6M | 95.0M | (6.5M) | (5.9M) | (5.6M) | |
Total Operating Expenses | 1.4B | 1.9B | 1.7B | 1.3B | 1.2B | 1.2B | |
Tax Provision | (5.6M) | (1.5M) | 1.0M | (56.5M) | 33.2M | 34.8M | |
Net Interest Income | 3.9M | (2.9M) | (40.5K) | 2.3M | 5.1M | 5.4M | |
Interest Income | 7.7M | 8.7M | 5.2M | 6.9M | 8.7M | 7.8M | |
Ebitda | 122.5M | 440.6M | 111.0M | (254.9M) | (229.4M) | (218.0M) | |
Reconciled Depreciation | 39.6M | 55.1M | 6.0M | 125.0M | 95.9M | 60.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Shenzhen Stock
Shenzhen Glory Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Shenzhen Glory shareholders. The income statement also shows Shenzhen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).